The CTC offices are currently closed for refurbishment. Access to trial TMFs and patient records will be limited during this period. We will still be able to receive post during this time, but there may be a small delay in responding to this. Our fax lines may also be subject to disruption. Where possible, please direct all correspondence via email to trial-specific email addresses. We appreciate your patience and understanding.

Due to COVID-19 and current government guidance, UCL CTC staff continue to work remotely with limited access to the office. Please continue to email the trial specific mailbox with any urgent queries. For paper CRF trials, please continue to copy and scan CRFs to the trial inboxes (remove all patient identifiers except Trial Number and Initials) until further notice.

Trials portfolio
GALA-5 Long Term Follow Up
Long term follow up of patients in the GALA5 trial: an Evaluation of the Tolerability and Feasibility of combining 5-Amino-Levulinic Acid (5ALA) with Carmustine Wafers (Gliadel) in the Surgical Management of Primary Glioblastoma
The GALA-5 trial was a single arm feasibility study to evaluate the safety and tolerability of combining 2 technologies (5-ALA and Carmustine wafers) in the surgical management of patients with gliobl [...]
Area: Brain cancer
Phase: Observational trials
Status: In follow-up (non-recruiting)
A randomised phase 2 trial investigating the additional benefit of hydroxychloroquine (HCQ) to short course radiotherapy (SCRT) in patients aged 70 years and older with high grade gliomas (HGG)
HCQ is a randomised (2:1), multicentre, phase II study comparing hydroxychloroquine (HCQ) and short course radiotherapy (SCRT) with SCRT alone to examine the effect on one-year survival in patients ag [...]
Area: Brain cancer
Phase: Phase II
Status: In follow-up (non-recruiting)
A randomized phase II trial of Hippocampal Sparing versus Conventional Whole Brain Radiotherapy after surgical resection or radiosurgery in favourable prognosis patients with 1-4 brain metastases
HIPPO is a 1:1 randomised multicentre phase II study investigating Hippocampal Sparing Whole Brain Radiotherapy (HS-WBRT) versus standard Whole Brain Radiotherapy (WBRT) after neurosurgery or stereota [...]
Area: Brain cancer
Phase: Phase II
Status: In follow-up (non-recruiting)
Contact Us
Cancer Research UK & UCL Cancer Trials Centre
University College London
90 Tottenham Court Road

View map
+44 (0)20 7679 9898 (General CTC Enquiries)
020 7679 9899
University College London, Gower Street, London, WC1E 6BT +44 (0)20 7679 2000

Copyright © 2021 UCL | Disclaimer | Freedom of Information | Accessibility | Privacy | Cookies | Contact Us